HST Global Announces Saudi Arabian Project

HST Global, Inc. Announces the Launch of a Project with EBITDA Capital, LLC Within the Kingdom of Saudi Arabia

HAMPTON, Va.--()--HST Global, Inc. (OTCBB:HSTC), an integrated biotechnology health and wellness company, today announced a project that has been initiated with EBITDA Capital, LLC for both shareholder participation and health and wellness center operations within Saudi Arabia.

HST Global, Inc has given authority to EBITDA Capital, LLC to begin working with EBITDA’s contacts and clients within the Kingdom of Saudi Arabia. Key clientele within the Royal Family have expressed an interest in becoming shareholders in HSTC. In addition, they have shown an interest in opening and operating a health and wellness clinic based within the Gulf Cooperation Council Countries (GCC). The health and wellness clinics would include both for-profit and non-profit treatment facilities in support of HSTC’s late stage cancer applications. HSTC would be responsible for the training, maintenance and management development in these clinics.

Mr. Chet Noblett, Managing General Partner of EBITDA, is currently assisting HSTC with the initial negotiations and is leveraging his long term relationships with these parties. Mr. Noblett says, “We have been cautiously opening the window of opportunity for HSTC with our associates in Saudi Arabia. Health care is a top priority throughout the GCC and HSTC offers the opportunity to energize the effort by establishing these clinics. We are very pleased to have the level of interest and acceptance that has been expressed at this time.”

Ron Howell, President and CEO of HST Global, Inc., stated, “The commencement of this initiative within the GCC Countries characterizes the essence of what HSTC is developing. The combined capital and strategic operational partnership will bring an affordable, yet cost effective treatment for late stage cancer to the GCC. HSTC is reaching across the Globe with its brand of alternative health and wellness centers.”

HSTC also has plans to establish clinics modeled after the GCC project within a number of Asian markets where EBITDA has already made initial contacts.

About HST Global, Inc.

HST Global, Inc. is an Integrated Biotechnology Health and Wellness company that is developing and or acquiring a network of Wellness Centers worldwide that are primarily focused on the homeopathic and alternative treatment of late stage cancer. In addition, the company intends to acquire innovative products for the treatment of late stage cancer. In this regard, the company primarily focuses on homeopathic and alternative product candidates that are undergoing or have already completed significant clinical testing for the treatment of late stage cancer.

Contacts

HST Global, Inc.
Investor Relations
David Nesbitt, 757-766-6100
ir@hstglobal.com
www.hstglobal.com

Contacts

HST Global, Inc.
Investor Relations
David Nesbitt, 757-766-6100
ir@hstglobal.com
www.hstglobal.com